Below, CNBC Select explains the differences between trademarks, copyrights and patents. Read on for more information and to ...

Speaking at CDMI Europe 2025, GlobalData pharma analyst George El-Helou says the use of AI in R&D could help mitigate patent ...

Frivolous suits may have reached a new, dangerous level in one firm’s alleged $1 million bounty for third-party legal ...

The CAFC on Tuesday issued a precedential decision affirming a district court’s award of more than $250,000 in attorneys’ ...

Introduction - Far too often, startup founders treat intellectual property (IP)—especially patents—like an item on a to-do list.

This is what happens when Big Pharma values patents and profits over the people who need affordable, life-saving medication.

As the 2025 UK Autumn Budget approaches with productivity and growth top of mind, a new survey finds that AI assisted research could unlock millions of R&D hours.

The U.S. District Court for the District of Columbia on Thursday rejected Teva Pharmaceuticals’ challenge to the Medicare ...

The US Court of Appeals for the Federal Circuit affirmed attorneys’ fees awards against EscapeX IP, LLC, finding the case “exceptional” under ...

After a long hiatus, why are the bulls so willing to buy in now?

U.S. patent litigation, driven by pro-patent policies, advanced AI tools, and increased litigation funding, all boosting enforcement and enforcement success.